Borosil Scientific Limited
3,236words
9turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
6.5GW
₹7223
₹2739
₹1267
12.1%
10.6%
42.2%
87.6%
23.9%
17.6%
18.8%
Guidance — 6 items
Note
opening
“15 Key Highlights of Financial Results FY26 ❖ Standalone and Consolidated Operating EBITDA and EBIT exclude: - - Investment Income of Rs.”
Note
opening
“2.68 crores in FY26 and FY25 respectively.”
Note
opening
“2.12 crores in FY25 ❖ Despite the impact of one-time expenses related to the discontinued operations at the Ambad manufacturing plant (excluding VRS expenses) which includes discard of fixed assets, the Company achieved growth in Standalone EBITDA during FY26.”
Note
opening
“❖ In FY26, Company has reported exceptional items of Rs.”
Note
opening
“1.92 crores ❖ Consolidated PAT is further supported by recognition of Deferred Tax Asset in Goel Scientific Glass Works Limited on its losses in FY26.”
Note
opening
“Further, execution of certain high-value orders has been deferred to subsequent quarters, which impacted Q4FY26 revenues and, consequently, full-year FY26 performance.”
Risks & concerns — 1 flagged
2.12 crores in FY25 ❖ Despite the impact of one-time expenses related to the discontinued operations at the Ambad manufacturing plant (excluding VRS expenses) which includes discard of fixed assets, the Company achieved growth in Standalone EBITDA during FY26.
— Note
Speaking time
4
2
1
1
1
Opening remarks
Sub
Investor presentation on the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2026 Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the presentation on the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended March 31, 2026. said The https://www.borosilscientific.com/. presentation is also hosted on the Company's website at Please take the above on record. Yours faithfully, For Borosil Scientific Limited Ramavtar Sharma Company Secretary & Compliance Officer Encl: as above Enabling the Future of Science Investor Presentation Q4FY26 Safe Harbour This investor presentation has been prepared by Borosil Scientific Limited (“Company”) on a strictly confidential basis. Certain statements in this presentation may be ‘forward-looking statements’ wit
Trusted Worldwide
NABL accredited Calibration Lab; ISO 9001:2015, 14001, 45001, and 15378 Certifications Default Choice 3 out Of 4 Lab Glassware Products In India Bear The Borosil Name. 4,000+ SKUs Pharmaceuticals, Academia, and across India. Serving Research, Industries 4 A Legacy of more than 6 decades… Current Indian promoters took over Entry into Pharma Primary Packaging with acquisition of Klasspack Pvt Ltd, Nasik Entry into Process Systems through acquisition of Goel Scientific Glass Works, Baroda Brand Borosil came into existence Shifted manufacturing base from Mumbai to Bharuch Instituted greenfield manufacturing plant for Laboratory Instruments, Pune Scientific Division demerged from Borosil Ltd on 2nd Dec 2023 and was listed as Borosil Scientific Limited on 7th June 1962 1988 2008 2016 2018 2023 2024 5 Vision To be the most customer-centric company Purpose Inspired by the possibilities of tomorrow, we create lab and process solutions that empower science, enhance lives, and enable a sustainabl
Note
15 Key Highlights of Financial Results FY26 ❖ Standalone and Consolidated Operating EBITDA and EBIT exclude: - - Investment Income of Rs. 7.02 crores and Rs. 2.68 crores in FY26 and FY25 respectively. - Interest Income on amount receivable from Borosil Limited on account of Scheme of Amalgamation is Rs. 2.12 crores in FY25 ❖ Despite the impact of one-time expenses related to the discontinued operations at the Ambad manufacturing plant (excluding VRS expenses) which includes discard of fixed assets, the Company achieved growth in Standalone EBITDA during FY26. ❖ In FY26, Company has reported exceptional items of Rs. 8.53 crores which includes: - - The Company had introduced a Voluntary Retirement Scheme for the eligible workers at its Ambad, Nashik Plant by entering the Memorandum of Settlement with the Bhartiya Kamgar Sena, the registered trade union representing these workers. This settlement, including related professional fees, resulted in an expense of Rs. 6.61 crores. - Gratuity a
Note
1) The Process Systems segment reported lower revenues during the period, primarily due to a sales reversal of INR 1.6 crore in Q4FY26 in line with Ind AS requirements. Further, execution of certain high-value orders has been deferred to subsequent quarters, which impacted Q4FY26 revenues and, consequently, full-year FY26 performance. 17 Customers in Scientific Segment Emphasis on Widening Our Footprint Across Key Customer Segments ✔ Perfectly aligned product range of Borosil Scientific to serve the growing industry & like Beverage, Feed, Dairy etc. segments Food ✔ Launch of Biopharma SHAKTI in the Union Budget 2026-27 will pave the way for growth of our products in biologics and biosimilars FY25 18 Growth Theme 01 02 03 04 Capitalizing on the ‘Make in India’ Initiative Borosil Scientific is a strong proponent of the ‘Make in India’ initiative, which champions domestic manufacturing and innovation Leveraging the Brand ‘BOROSIL’ New Product Development Focus on Exports Borosil is a trus
Estimated Market Growth
12% to 14% Glassware Segment Pharmaceutical Primary Packaging Serviceable Addressable Market : ₹1377 Cr
Estimated Market Growth
6% to 8% Market size : ₹490 Cr Borosil Share : ~33% Source: F&S 2019, 2022 reports, Industry & Internal Estimates 21 New Product Development Fat with Randall Fiber with Fiber bags Moisture Analyser Handheld Photometer Vial Inserts Micro Vials UV-Visible Spectrophotometer e-Dispenser e-Titrate Overhead Stirrer Hot plate Stirrer Quartz Distillation Unit 22 From Distrillation to Purification H2O pure. Pure and ultrapure water. ISI Glassware Certification Achieved within 6 Months NO. 1 IN KJELDAHL Approx 750+ installations in 5 Years Patented Bottle Top Dispenser DIY CALIBRATION A PATENTED PRODUCT 8000+ in last 3 years Worldwide Product Presence 90+ Countries Laboratory Glassware Pharma Primary Packing Vials & Ampoules 28 Certifications QMS for Design, Development, Manufacture & Supply of Scientific Laboratory Equipment & Instruments by TÜV Nord Cert GmbH for QMS and manufacturing Glass of supply Ampoules and Vials by TÜV India Good Manufacturing Practice (GMP) for manufacturing of Glass A